For a small subset, a very small subset of people, maybe it works
We need to have a more balanced conversation about GLP-1 medications
In summary, choosing between GLP-1 agonists and SGLT2 inhibitors should be based on a patients specific health needs and any existing cardiovascular, renal, or neurological conditions
For weight loss, Zepbound (tirzepatide) produces greater average weight reduction than semaglutide medications like Ozempic and Wegovy
In particular, tell your provider if you have a past history of: Type 1 or type 2 diabetes Thyroid cancer Gastrointestinal disease Pancreatitis Kidney disease Diabetic retinopathy Depression Suicidal thoughts or behavior Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding
The term "targeted" isn't just marketing speak